32. Borghaei H, Paz -Ares L, Horn L, et al. Nivolumab versus docetaxel in advanced nonsquamous non- small - cell lung cancer. N Engl J Med 2015; 373: 1627- 1639. 33. Cuppens K, Vansteenkiste J. Vaccination therap y for non -small -cell lung cancer. Curr Opin Oncol 2014; 26: 165-170. 34. Rosenberg SA, Yang JC, Restifo NP. Cancer immunotherap y: Moving beyond current vaccines.Nat Med 2004; 10: 909 - 915. 35. Hellman MD et al., Nivolumab plus ipilimumab as first -line treatment for advanced non-small -cell lung cancer (CheckMate 012): results of an open -label, phase 1, multicohort study Lancet Oncol. 2017; 18(1):31 -41.